According to Goldstein Research, India is supplier of approximately 20% of generic medicines across the globe, in terms of volume which makes it a largest provider of generic medicines globally and the volumes are projected to expand in coming years.
India Pharmaceutical Industry
PR-Inside.com: 2018-09-14 13:03:03
According to Goldstein Research, India is supplier of approximately 20% of generic medicines across the globe, in terms of volume which makes it a largest provider of generic medicines globally and the volumes are projected to expand in coming years. Huge expenditures by the Indian government to modernize the healthcare infrastructure and market players significant investment over R&D activities is also driving the growth of the pharmaceutical industry in India. India Pharmaceutical market outlook also includes new business models, technological advancements, and capital investment as the key strategies adopted by the major players for significant expansion of business in India. Furthermore, Epidemiological factors such as 20% growth in the patient pool, new diseases and increasing pervasiveness of lifestyle diseases will boost the pharmaceuticals industry in India.
Browse Full Report:
On the basis of our in-depth analysis, India Pharmaceutical market can be segmented as follows:
• Active Pharmaceutical Ingredients (APIs)
• Contract Research and Manufacturing Services
• Formulations (CRAMS)
• Gastro Intestinal
• Tier- I Cities Pharmaceutical Market
• Tier- II Cities Pharmaceutical Market
• Tier- III Cities Pharmaceutical Market
“India Pharmaceutical Market Outlook 2024” contains detailed overview of the India pharmaceutical market. On the basis of our in-depth analysis, market can be segmented in terms of market segmentation by active pharmaceutical ingredients, contract research and manufacturing Services, formulations (CRAMS) and biosmililars.
Download Exclusive sample Report:
Further, for the in-depth analysis, India Pharmaceutical Market Report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis. This market report also includes competitive outlook of some of the major players profiling of companies such as Sun Pharma, Dr Reddy, Lupin, Cipla, Aurbindo, Candila. Glenmark, Torrent Pharma, Alkem Lab GlaxoSmithkline and Abbott India.The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments.Overall, the report represents the India pharmaceutical market trends along with market forecast that will help industry consultants, technology providers, existing players searching for expansion opportunities, new players examining possibilities and other stakeholders to bring into line their market centric approaches according to the ongoing and expected trends in the future.
Key queries countered in this India pharmaceutical market report
• What is the India pharmaceutical market size by 2024 and what would be the expected growth rate of sales?
• What are the pharmaceutical market trends?
• What are the dynamics which are driving this market?
• What are the major barriers to pharmaceutical market growth?
• Who are the prominent vendors in this market space?
• What are the market prospects for the current and entry level players?
• What are the latest improvements and market strategies of the key players?
Browse Similar Report:
99 Wall Street, Suite No:- 527
Global Sales Manager
# 528 Words